| Market Cap | ₹1,980Cr |
| ROE | 12.06% |
| P/E Ratio(TTM) | 30.39 |
| EPS(TTM) | 30.92 |
| P/B Ratio | 3.91 |
| Dividend Yield | 0.61% |
| Industry P/E | 34.91 |
| Book Value | 239.99 |
| Debt to Equity | 0.06 |
| Face Value | 5 |
| Parent Organisation | Windlas Biotech |
| NSE Symbol | WINDLAS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.78 | ||
| Gland Pharma | NA (0.00%) | 41.01 | ||
| Ajanta Pharma | NA (0.00%) | 32.12 | ||
| Eris Lifesciences | NA (0.00%) | 54.10 |